Product Information
ERYTHROMYCIN 400 MG/5 ML SUSP is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $1.7254 per ML under NDC 60219150402. Its NADAC has been published 116 times since Jun 5, 2024.
FDA first approved this application on Nov 1, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/5mL
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219150402
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ERYTHROMYCIN ETHYLSUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA211204FDA Approved
11/1/2019
TE Code
AB
On Market Since
12/2/2023
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has been published 116 times since Jun 5, 2024, and over the history we have for it it has declined 19.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7254 per ML |
|---|---|
| All-time high | $2.2830 (Oct 15, 2025) |
| All-time low | $1.7254 (Aug 19, 2026) |
| 52-week high | $2.2830 |
| 52-week low | $1.7254 |
| Median price | $1.9387 |
| Average price | $1.9515 |
| Largest weekly change | -15.4% (Jul 17, 2024) |
| Weeks tracked | 116 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 400 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 400 MG/5 ML SUSP, manufactured by Amneal Pharmaceuticals NY LLC, is $1.7254 per ML (NDC 60219150402), effective Aug 19, 2026.
How has the price of ERYTHROMYCIN 400 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has declined 19.9%. It has been tracked across 116 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 400 MG/5 ML SUSP?
Since Jun 5, 2024, the NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has ranged from a low of $1.7254 (Aug 19, 2026) to a high of $2.2830 (Oct 15, 2025), with a median of $1.9387 per ML.
Are there cheaper alternatives to ERYTHROMYCIN 400 MG/5 ML SUSP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ERYTHROMYCIN 400 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures ERYTHROMYCIN 400 MG/5 ML SUSP?
ERYTHROMYCIN 400 MG/5 ML SUSP (NDC 60219150402) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.